Roivant Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ROIV and other ETFs, options, and stocks.About ROIV
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses.
CEOMatthew Gline
CEOMatthew Gline
Employees904
Employees904
HeadquartersLondon, Greater London
HeadquartersLondon, Greater London
Founded2014
Founded2014
Employees904
Employees904
ROIV Key Statistics
Market cap9.02B
Market cap9.02B
Price-Earnings ratio2.15
Price-Earnings ratio2.15
Dividend yield—
Dividend yield—
Average volume4.34M
Average volume4.34M
High today$11.35
High today$11.35
Low today$10.90
Low today$10.90
Open price$10.98
Open price$10.98
Volume5.56M
Volume5.56M
52 Week high$13.24
52 Week high$13.24
52 Week low$8.06
52 Week low$8.06
Analyst ratings
92%
of 12 ratingsBuy
91.7%
Hold
8.3%
Sell
0%